Join the club for FREE to access the whole archive and other member benefits.

Bryant Villeponteau

President and CSO of Centagen.

Bryant Villeponteau, Ph.D. has 30 years of scientific leadership experience and about 60 journal and patent publications. Dr. Villeponteau holds a B.A. in Economics, a M.A. in Biostatistics, and a Ph.D. in Molecular Biology from UCLA. Bryant was Assistant Research Chemist in the Department of Chemistry and Biochemistry at UCLA for 4 years and Assistant Professor of Biological Chemistry at the University of Michigan Medical School for 6 years. Bryant then led a research group at Geron Corporation for 4.5 years, where he was the lead inventor in cloning human telomerase, thereby wining the Distinguished Inventor Award for the 2nd best US patent of 1997. As the Champion of Telomerase Therapeutics at Geron, he also worked on human stem cells, which were pioneered by Geron in the 90s. Bryant then joined HealthSpan Sciences, Inc. as CSO and later served as CEO for three years. For the next 8 years, Dr. Villeponteau served as a VP/consultant for Sierra Sciences. From September of 2008 to present, Dr. Villeponteau has been the VP of R & D with Genescient Corporation. Bryant also cofounded Centagen, incorporated in January of 2009, and Life Code LLC in October of 2010 to market Stem Cell 100TM.

Visit website:


See also: Company Centagen - Company developing multi-path therapeutics for age-related disorders via activating adult stem cells

Bryant Villeponteau News

Organ, tissue replacement could end aging by mid-2020s

Institute for Ethics and Emerging Technologies (IEET) - 14-May-2013